zur Navigation zum Inhalt
Onkologie 14. Jänner 2011

Lung cancer – ASCO 2010

Lung cancer remains a disease difficult to treat. Accordingly, results from recently conducted clinical trials are eagerly awaited. Every year, the American Society of Clinical Oncology (ASCO) – Annual Meeting provides the oncological community with a large number of such studies, with some of them potentially changing current treatment standards. The aim of this review is therefore to give a concise overview on this year's Annual Meeting presentations covering the field of lung cancer with an emphasis on randomized phase III trials of immediate clinical importance.

Zu diesem Thema wurden noch keine Kommentare abgegeben.

Mehr zum Thema

<< Seite 1 >>

Medizin heute

Aktuelle Printausgaben